p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients.

about

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.

P2860

Q55450892-393C419A-EB51-4E05-8AC1-76DB1D3BB482

P2860

p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients.

Item

http://www.wikidata.org/entity/Q55029689

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

p-MAPK1 expression associated ...... stic T-cell lymphoma patients.

@en

p-MAPK1 expression associated ...... stic T-cell lymphoma patients.

@nl

type

Item

label

p-MAPK1 expression associated ...... stic T-cell lymphoma patients.

@en

p-MAPK1 expression associated ...... stic T-cell lymphoma patients.

@nl

prefLabel

p-MAPK1 expression associated ...... stic T-cell lymphoma patients.

@en

p-MAPK1 expression associated ...... stic T-cell lymphoma patients.

@nl

P1476

p-MAPK1 expression associated ...... stic T-cell lymphoma patients.

@en

P2093

Javier Menárguez

http://www.w3.org/2001/XMLSchema#string

M Ángeles Pérez-Sáenz

http://www.w3.org/2001/XMLSchema#string

Mónica García-Cosio

http://www.w3.org/2001/XMLSchema#string

Nerea Carvajal

http://www.w3.org/2001/XMLSchema#string

Pilar Llamas

http://www.w3.org/2001/XMLSchema#string

Rebeca Manso

http://www.w3.org/2001/XMLSchema#string

Socorro M Rodríguez-Pinilla

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of the BRAF gene in human cancer

Targeting the ERK signaling pathway in cancer therapy.

Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo

High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade.

From empiric to mechanism-based therapy for peripheral T cell lymphoma.

MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma.

Genomic landscape of cutaneous T cell lymphoma.

Involvement of Cot activity in the proliferation of ALCL lymphoma cells.

The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature

P304

661-664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.13972

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P50

Santiago Montes-Moreno

P577

2016-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26915336

http://www.w3.org/2001/XMLSchema#string

p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients.

about

P2860

P2860

p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698